Back to blog
20 August 2026

New Hope for Dementia with Lewy Bodies and Liver Cancer Treatments

The UK's licensing pathway has fast-tracked promising new investigational treatments for dementia with Lewy bodies and liver cancer.

The UK has fast-tracked two promising new investigational treatments for liver cancer and progressive dementia with Lewy bodies.

What These New Treatments Mean

  • Dementia with Lewy bodies is a complex, progressive neurological condition affecting many families.
  • Hepatocellular carcinoma is the most common form of liver cancer in the UK.
  • Innovation Passports speed up regulatory guidance to help get safe drugs to patients sooner.
  • Both treatments are still in development and require final evidence of safety and effectiveness.

Next Steps and Key Dates

  • Future availability depends on final testing to prove clinical safety and value.
  • Drug developers can apply for the next licensing round until 4 November 2026.
  • Detailed guidance for innovative medicine applications is available on the MHRA website.

Source: www.gov.uk